Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
The Journal of Knee Surgery|February 22, 2021
Impact of Postoperative Opioid Use on 2-Year Patient-Reported Outcomes in Knee Surgery PatientsXuyang Song, Patrick M J Sajak, Ali Aneizi, et al.Drug Discovery Today|January 23, 2026
Organoids in drug development: from predictive models to regulatory integrationXuyang Song, Xinrong Chen, Qing Chen, et al.Clinical Pharmacology and Therapeutics|December 16, 2017
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease StatusPaul G Baverel, Vincent F S Dubois, Chao Yu Jin, et al.Clinical Pharmacology and Therapeutics|July 8, 2023
Modeling of Proliferating CD4 and CD8 T-Cell Changes to Tremelimumab Exposure in Patients with Unresectable Hepatocellular CarcinomaXuyang Song, Robin Kate Kelley, Michelle Green, et al.Clinical Pharmacology and Therapeutics|October 1, 2023
Population Pharmacokinetics and Exposure-Response Analysis for the CTLA-4 Inhibitor Tremelimumab in Metastatic NSCLC Patients in the Phase III POSEIDON StudyJimmy Zhijian He, Vincent Duval, Petra Jauslin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2022
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell CarcinomaMartin H Voss, Arun A Azad, Aaron R Hansen, et al.British Journal of Clinical Pharmacology|December 1, 2022
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearanceMichael Hwang, Yen Lin Chia, Yanan Zheng, et al.Journal of Clinical Pharmacology|February 28, 2023
Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid TumorsMichael Hwang, Chunling Fan, Mun Sang Yue, et al.Clinical and Translational Science|January 27, 2021
Evolving drug regulatory landscape in China: A clinical pharmacology perspectiveWeifeng Tang, Ying Huang, Diansong Zhou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2022
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular CarcinomaXuyang Song, Robin Kate Kelley, Anis A Khan, et al.Pageof 4